Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» nasal polyps
nasal polyps
FDA says no to AZ’s Fasenra for nasal polyp indication
Pharmaforum
Mon, 03/14/22 - 10:19 am
AstraZeneca
Fasenra
nasal polyps
Amgen builds case for severe asthma drug tezepelumab
Pharmaforum
Mon, 09/6/21 - 09:11 pm
Amgen
AstraZeneca
tezepelumab
asthma
nasal polyps
GlaxoSmithKline's Nucala beats AZ's Fasenra to the IL-5 punch in nasal polyps
Fierce Pharma
Thu, 07/29/21 - 11:04 pm
GSK
Nucala
nasal polyps
FDA
AstraZeneca's asthma drug succeeds late-stage study
Reuters
Thu, 09/10/20 - 10:35 am
AstraZeneca
Fasenra
asthma
nasal polyps
clinical trials
AnaptysBio's etokimab provides more disappointing results, raising questions about compound's future
Endpoints
Mon, 08/10/20 - 11:01 am
AnaptysBio
rhinosinusitis
etokimab
clinical trials
nasal polyps
GSK's asthma biologic Nucala is one step closer to approval in key chronic rhinosinusitis population
Endpoints
Fri, 04/3/20 - 11:12 am
GSK
Nucala
rhinosinusitis
nasal polyps
clinical trials
Sanofi and Regeneron's Dupixent scores 3rd FDA approval in sinusitis with nasal polyps
Fierce Pharma
Wed, 06/26/19 - 05:21 pm
Sanofi
Regeneron
Dupixent
rhinosinusitis
nasal polyps
FDA
Sanofi/Regeneron’s Dupixent shows more promise in nasal polyps
Pharmaforum
Tue, 02/26/19 - 11:48 pm
Sanofi
Regeneron
Dupixent
clinical trials
nasal polyps
Regeneron, Sanofi talks up potential blockbuster franchise as Dupixent sweeps in rhinosinusitis PhIII
Endpoints
Tue, 10/16/18 - 11:44 am
Regeneron
Sanofi
Dupixent
nasal polyps
rhinosinusitis
Sanofi indicates dupilumab could be used to treat nasal polyps
Yahoo/Reuters
Wed, 09/13/17 - 09:35 am
Sanofi
dupilumab
Dupixent
nasal polyps